What is Sun Pharmaceutical Industries Ltd's PE ratio?

Sun Pharmaceutical Industries Ltd trades at a P/E ratio of 36.10.

What is Sun Pharmaceutical Industries Ltd's market cap?

Sun Pharmaceutical Industries Ltd's market capitalisation is ₹4.56L Cr.

When did Sun Pharmaceutical Industries Ltd last report results?

Sun Pharmaceutical Industries Ltd last reported Q1FY27 results on 31 Jul '26.

What is Sun Pharmaceutical Industries Ltd's ROE?

Sun Pharmaceutical Industries Ltd's return on equity (ROE) is 16.0%.

What sector is Sun Pharmaceutical Industries Ltd in?

Sun Pharmaceutical Industries Ltd (SUNPHARMA) is classified in the Healthcare sector (Pharmaceuticals).

Healthcare · Pharmaceuticals

Sun Pharmaceutical Industries Ltd (SUNPHARMA)

₹1,886.90

Mkt cap

₹4.56L Cr

P/E ratio

36.10

P/B

5.42

Div yield

0.84%

ROE

16.00%

ROCE

20.50%

EPS (TTM)

₹52.27

Book value

₹348

52W range

1,565–2,001

Sector

Healthcare

Price history

Previous close

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market. [1] It is the largest pharmaceutical company in India. [2]

NSE SUNPHARMABSE 524715

Health check

Constructive

ValuationFair

ProfitabilityStrong

GrowthModerate

TechnicalsNeutral

52-week range

−5.71% from high

₹1,887

₹1,565+20.55% from low₹2,001

Current

₹1,886.90

Prev close

₹1,899.00

Day

−0.64%

Price performance

−0.64%

−4.93%

−2.99%

+6.07%

+7.79%

+20.70%

YTD

+9.20%

Financials

Revenue, profit & margin

P/E ratio

36.1×

SUNPHARMA is 6% above the sector median of 34.0×

SUNPHARMA36.1×

Sector median34.0×

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	11,941	12,192	12,381	11,983	12,653	13,291	13,675	12,959	13,851	14,478	15,521	14,612	15,300
Expenses	8,609	9,013	8,904	8,948	9,045	9,352	9,666	9,243	9,550	9,951	10,572	10,658	10,882
Operating Profit	3,332	3,179	3,477	3,035	3,608	3,939	4,009	3,716	4,302	4,527	4,948	3,954	4,418
OPM %	28%	26%	28%	25%	29%	30%	29%	29%	31%	31%	32%	27%	29%
Other Income	-118	294	180	504	533	354	149	251	-354	470	89	458	520
Interest	81	49	35	74	62	69	52	49	75	100	78	86	100
Depreciation	651	633	622	650	655	626	631	664	701	730	732	775	739
Profit before tax	2,481	2,791	3,000	2,816	3,424	3,598	3,476	3,254	3,173	4,168	4,227	3,551	4,099
Tax %	19%	14%	14%	5%	16%	16%	16%	34%	27%	25%	20%	23%	29%
Net Profit	2,006	2,385	2,561	2,659	2,861	3,037	2,913	2,154	2,293	3,125	3,381	2,710	2,901
EPS in Rs	8.43	9.90	10.52	11.06	11.82	12.67	12.10	8.96	9.50	13.00	14.04	11.31	12.06
Raw PDF

Earnings

Results dates & reactions

No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +0.12% · closed higher next day 28 of last 61

	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25	Q4FY25	Q1FY26	Q2FY26	Q3FY26	Q4FY26	Q1FY27
Broadcast	1 Nov '23◦	31 Jan '24◦	22 May '24◦	1 Aug '24◦	28 Oct '24◦	31 Jan '25◦	22 May '25◦	31 Jul '25	5 Nov '25◦	31 Jan '26◦	22 May '26	31 Jul '26◦
Earnings day	+1.49%	−0.74%	−2.87%	+0.96%	−1.64%	−0.10%	−2.04%	−1.56%	−0.24%	+2.04%	−2.47%	−1.36%
+1 day	+2.23%	−0.13%	−3.42%	+0.30%	−2.67%	−0.19%	−2.48%	−6.00%	+0.08%	+6.69%	−2.68%	−1.33%
+5 days	+5.38%	+5.72%	−5.21%	+1.17%	−3.97%	+0.34%	−2.39%	−7.81%	+2.80%	+6.85%	−5.01%	−2.32%
+15 days	+7.10%	+9.84%	−1.85%	+3.34%	−5.65%	−5.75%	−1.80%	−5.31%	+7.12%	+8.59%	−4.51%	−4.04%
+30 days	+12.23%	+9.15%	+1.89%	+8.61%	−4.70%	+0.22%	−2.47%	−7.60%	+3.31%	+12.48%	+0.64%	—
Filing	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL	XBRL

Corporate actions

Last 6 months

Kind	Value	Ex-date	Record
dividend Dividend - Rs 5 Per Share	5.00	7 Jul '26	7 Jul '26

Results analysis

Shareholding

as of Jun 2026

54.48%Promoter

Promoters54.48%

FIIs14.54%1.40

DIIs22.06%1.06

Public8.81%0.33

Government0.11%

Ownership trend

Peers

7 companies

Valuation vs quality

P/E × ROCE · bubble = market cap

Name	CMP	P/E	Mkt Cap	Div Yld	NP Qtr	Qtr Profit Var	Sales Qtr	Qtr Sales Var	ROCE
SUNPHARMA	₹1,899.00	36.07	4,55,634	0.84%	2,901	+5.95%	15,300	+10.46%	20.53%
DIVISLAB	₹9,100.00	81.09	2,41,576	0.33%	902	+65.50%	3,080	+27.80%	21.97%
TORNTPHARM	₹4,857.00	82.80	1,84,745	0.78%	566	+5.79%	4,921	+54.85%	15.19%
CIPLA	₹1,385.00	31.26	1,11,888	0.94%	786	−39.19%	7,119	+2.33%	15.49%
ZYDUSLIFE	₹1,120.00	22.95	1,11,720	0.09%	990	−35.09%	8,017	+21.96%	21.14%
LAURUSLABS	₹1,840.00	90.93	99,417	0.11%	362	+125.49%	2,026	+29.10%	17.76%
LUPIN	₹2,110.00	16.20	96,483	0.85%	1,417	+16.08%	8,277	+32.04%	29.93%
Median: 158 Co.	₹421.50	33.96	2,277	0.08%	13	+30.25%	164	+18.67%	14.96%

Filings

Annual reports15

Annual Report 2026bse Annual Report 2025bse Annual Report 2024bse Annual Report 2023bse Annual Report 2022bse Annual Report 2021bse Annual Report 2020bse Annual Report 2019bse Annual Report 2018bse Annual Report 2017bse Annual Report 2016bse Annual Report 2015bse Annual Report 2014bse Annual Report 2013bse Annual Report 2012bse

Credit ratings6

Rating update 4 Augcrisil Rating update 6 Maycrisil Rating update 5 Mayicra Rating update 17 Marcrisil Rating update 3 Maricra Rating update 4 Aug 2025crisil

Announcements5

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 3 Sep Announcement under Regulation 30 (LODR)-Press Release / Media Release 1 Sep - Sun Pharma joins White House deal on MFN pricing and delayed Section 232 tariffs.Announcement under Regulation 30 (LODR)-Newspaper Publication 26 Aug Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 25 Aug Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 25 Aug